Gabriel Gomis

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Lymph Node Metastasis

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science advances

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alvaro Teijeira, Saray Garasa, María Carmen Ochoa, Sandra Sanchez-Gregorio, Gabriel Gomis, Carlos Luri-Rey, Rafael Martinez-Monge, Beatrice Pinci, Karmele Valencia, Belen Palencia, Benigno Barbes, Elixabet Bolaños, Arantza Azpilikueta, Marina Garcia-Cardosa, Javier Burguete, Iñaki Eguren, Eneko Garate-Soraluze, Pedro Berraondo, Jose-Luis Perez-Gracia, Carlos E De Andrea, Maria E Rodríguez-Ruiz, Ignacio Melero Bermejo
Low-dose ionizing γ-radiation elicits the extrusion of neutrophil extracellular traps. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Javier Glez-Vaz, Arantza Azpilikueta, María Carmen Ochoa, Irene Olivera, Gabriel Gomis, Assunta Cirella, Carlos Luri-Rey, Maite Alvarez, Jose-Luis Perez-Gracia, Sergio Ciordia, Iñaki Eguren, Raluca Alexandru, Pedro Berraondo, Carlos E De Andrea, Alvaro Teijeira, Fernando Corrales, Juan M Zapata, Ignacio Melero Bermejo
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects. Science advances 9 (33) (2023)
Irene Olivera, Carlos Luri-Rey, Alvaro Teijeira, Iñaki Eguren, Gabriel Gomis, Belen Palencia, Pedro Berraondo, Ignacio Melero Bermejo
Facts and hopes on neutralization of protumor inflammatory mediators in cancer immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ignacio Melero Bermejo, Maria C Ochoa, Carmen Molina, Sandra Sanchez-Gregorio, Saray Garasa, Carlos Luri-Rey, Sandra Hervas-Stubbs, Noelia Casares, Edurne Elizalde, Gabriel Gomis, Assunta Cirella, Pedro Berraondo, Alvaro Teijeira, Maite Alvarez
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies. EMBO molecular medicine (2023)